Financial Services » Investing & Securities | Manhattan Scientifics Inc.

Manhattan Scientifics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
652.00
642.00
64.00
150.00
142.00
629
Cost of Goods Sold (COGS) incl. D&A
227.00
-
-
-
1,046.00
629
Gross Income
425.00
-
-
-
904.00
629
SG&A Expense
2,233.00
3,915.00
5,522.00
5,538.00
1,374.00
819
EBIT
1,808.00
3,475.00
6,251.00
6,383.00
2,278.00
1,448
Unusual Expense
-
-
14,938.00
763.00
3,823.00
6,886
Non Operating Income/Expense
-
-
-
-
1.00
-
Interest Expense
120.00
330.00
675.00
488.00
-
-
Pretax Income
1,928.00
3,805.00
8,012.00
6,108.00
1,546.00
8,334
Consolidated Net Income
1,928.00
3,805.00
8,012.00
6,108.00
1,546.00
8,334
Net Income
1,928.00
3,805.00
8,012.00
6,108.00
1,546.00
8,334
Net Income After Extraordinaries
1,928.00
3,805.00
8,012.00
6,108.00
1,546.00
8,334
Net Income Available to Common
1,928.00
3,805.00
8,012.00
6,108.00
1,546.00
8,334
EPS (Basic)
0.00
0.01
0.01
0.01
0.00
0.02
Basic Shares Outstanding
461,107.30
485,631.10
521,647.70
534,680.50
533,781.10
533,781.10
EPS (Diluted)
0.00
0.01
0.01
0.01
0.00
0.02
Diluted Shares Outstanding
461,107.30
485,631.10
593,445.90
534,680.50
533,781.10
533,781.10
EBITDA
1,581.00
3,273.00
5,458.00
5,388.00
1,421.00
826

About Manhattan Scientifics

View Profile
Address
The Chrysler Building
New York New York 10174
United States
Employees -
Website http://www.mhtx.com
Updated 07/08/2019
Manhattan Scientifics, Inc. focuses on technology transfer and commercialization of transformative technologies. The company operates as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields. It also focuses on identifing emerging technologies through strategic alliances with scientific laboratories, educational institutions, scientists and leaders in industry and government.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.